Delivery Order SPE2DB24D1007-SPE2DB24FBZZW
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rexulti 1 mg tablets, a prescription medication, with a ceiling value of $10,753.22 and a performance period through April 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Rexulti 0.5 mg tablet. The $13,088.31 firm fixed-price contract has an ultimate completion date of August 20, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Rexulti 0.5 mg tablets, a prescription medication. The delivery order has a ceiling value of $8,885.04 and a completion date of April 9, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,662.47, is for the delivery of Rexulti 2 mg tablets over the period ending on May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of the prescription medication Rexulti 3 mg tablets, with a total ceiling value of $11,651.00. The contract is firm-fixed price and has an ultimate completion date of August 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $30,591.65, is for the supply of Rexulti 1 mg tablets, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Rexulti 2 mg Tablet 30s. The fixed-price contract has a ceiling value of $6,148.66 and a performance period ending on May 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the prescription drug Rexulti 2 mg tablets. The contract has a firm fixed price of $3,736.47 and a period of performance through January 31, 2025. The contract was not subject to any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,264.26, is for the delivery of the prescription drug Rexulti 2 mg tablet in 30-count packages. The contract has a firm fixed price and an ultimate completion date of April 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Rexulti 1 mg tablets, a prescribed medication. The total ceiling value of this order is $3,894.40, with a firm fixed-price pricing type. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen, through its extensive federal contracting activities, has been a...